Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maria Nilsson, Danderyd Hospital
ClinicalTrials.gov Identifier:
NCT01789372
First received: February 5, 2013
Last updated: February 11, 2013
Last verified: February 2013

February 5, 2013
February 11, 2013
December 2009
June 2012   (final data collection date for primary outcome measure)
  • Quality of life [ Time Frame: Change from baseline in SF-36 after 12 weeks.Change from baseline in SF-36 after six months. ] [ Designated as safety issue: No ]
  • Quality of life [ Time Frame: Change from baseline in SF-36 after 12 weeks.Change from baseline in EQ-5D after six month ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01789372 on ClinicalTrials.gov Archive Site
  • Blood pressure [ Time Frame: Change from baseline in blood pressure after 12 weeks. Change from baseline in blood pressure after six months ] [ Designated as safety issue: No ]
  • heart rate [ Time Frame: Change from baseline in heart rate after 12 weeks.Change from baseline in heart rate after six months. ] [ Designated as safety issue: No ]
  • Heart variability [ Time Frame: Change from baseline in heart variability after 12 weeks.Change from baseline in heart variability after six months. ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation
Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation

The purpose of this study is to determinate if mediyoga has effects in quality of life, heart rate variability, blood pressure , heart rate in patients with paroxysmal atrial fibrillation (PAF).

This is randomized prospective pilot study. Eighty patients from Danderyd hospital, Stockholm, Sweden were randomized to either mediyoga group or control group. The mediyoga group were completing yoga for one hour, once a week for 12 weeks together with usual treatment. The controlgroup had only usual treatment.The usual treatment consists of pharmaceutical, cardio version and ablation. Quality of life ( SF-36, EQ-5d), blood pressure, heart rate and 24-hours ekokardiografi were measured at baseline and after twelve weeks.A follow up after six months was accomplished with SF-36 and EQ-5d, bloodpressure and heart rate.

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Primary care clinic. All participants should have been on usual treatment (medication, cardio version or ablation) for at least three months.

Paroxysmal Atrial Fibrillation
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
June 2012
June 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of PAF

Exclusion Criteria:

  • The exclusions criteria were multiple concurrent medical conditions and/or cognitive dysfunction (in the diagnosis of e.g. mental illness), considered not to be able to carry out yoga owing to ability to move and those who have difficulties to understand the Swedish language.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01789372
YOGAFF-001
Yes
Maria Nilsson, Danderyd Hospital
Danderyd Hospital
Not Provided
Study Director: Viveka Frykman, Phd, MD Danderyd hospital, Karolinska Institute Sweden
Danderyd Hospital
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP